IceCure Medical (ICCM) Current Deferred Revenue (2022 - 2025)

IceCure Medical (ICCM) has 4 years of Current Deferred Revenue data on file, last reported at $255000.0 in Q4 2025.

• Current Deferred Revenue for Q4 2025 came in at $255000.0, down 23.65% year-over-year; the trailing twelve-month figure through Dec 2025 was $255000.0 (down 23.65% YoY), and the FY2025 annual result was $255000.0, down 23.65% from the prior year.
• Current Deferred Revenue fell to $255000.0 in Q4 2025 per ICCM's latest filing, from $334000.0 in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $646000.0 in Q4 2022 and troughed at $187000.0 in Q4 2023.
• A 4-year average of $355500.0 and a median of $294500.0 in 2024 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue plunged 71.05% in 2023, then surged 78.61% in 2024.
• A 4-year view of Current Deferred Revenue shows it stood at $646000.0 in 2022, then sank by 71.05% to $187000.0 in 2023, then surged by 78.61% to $334000.0 in 2024, then declined by 23.65% to $255000.0 in 2025.
• Business Quant data shows ICCM's Current Deferred Revenue at $255000.0 in Q4 2025, $334000.0 in Q4 2024, and $187000.0 in Q4 2023.